Oncodesign’s General Meeting authorizes the allocation of Oncodesign Precision Medicine (OPM) shares to Oncodesign shareholders – La Bourse et la Vie TV

Oncodesigns General Meeting authorizes the allocation of Oncodesign Precision Medicine

Each Oncodesign shareholder will receive one OPM share for one ONCOSIGN share held DIJON, France–(BUSINESS WIRE)–Regulatory News: The General Meeting of Oncodesign (Paris:ALONC) held on September 30, 2022 authorized the distribution of OPM shares to Oncodesign shareholders. Each Oncodesign shareholder will receive one OPM share for one Oncodesign share held. No new shares will be … Read more

Oncodesign Precision Medicine (OPM) and Servier announce the signing of a strategic collaboration for the discovery of new therapeutic targets in the treatment of pancreatic cancer – La Bourse et la Vie TV

Oncodesign Precision Medicine OPM and Servier announce the signing of

Identification and validation of new therapeutic targets against pancreatic cancer Construction of a common Artificial Intelligence (AI) analytical platform Generation and pooling of clinical and biological data, AI tools and skills in experimental pharmacology Servier can initiate a partnership with OPM in Drug Discovery based on certain targets discovered thanks to this technological approach SURESNES, … Read more